Fagen Biomedical Inc.
Chongqing City, CN
|Fagen Biomedical Inc. Patent applications|
|Patent application number||Title||Published|
|20100150860||RECOMBINANT CHIMERIC PROTEIN OF NEUTROPHIL INHIBITORY FACTOR AND HIRUGEN, AND PHARMACEUTICAL COMPOSITION THEREOF - Provided is a chimeric protein comprising neutrophil inhibitory factor, the peptide FRRP specially recognizing the thrombin active site and hirugen. Also provided is a pharmaceutical composition comprising the chimeric protein, which can be used for treating or preventing cerebral injury and cerebral edema, inhibiting platelet aggregation etc.||06-17-2010|